BSE Live
Dec 29, 16:01Prev. Close
6423.15
Open Price
6430.90
Bid Price (Qty.)
6375.00 (4)
Offer Price (Qty.)
6490.00 (2)
NSE Live
Dec 29, 15:51Prev. Close
6427.50
Open Price
6450.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
6390.50 (135)
| Balance Sheet of Divis Laboratories (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 26.43 | 12.95 | 12.91 | 12.91 | 12.82 | |
| Total Share Capital | 26.43 | 12.95 | 12.91 | 12.91 | 12.82 | |
| Reserves and Surplus | 1,515.65 | 1,248.84 | 861.07 | 529.13 | 328.00 | |
| Total Reserves and Surplus | 1,515.65 | 1,248.84 | 861.07 | 529.13 | 328.00 | |
| Total Shareholders Funds | 1,542.08 | 1,261.79 | 873.99 | 542.05 | 340.82 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 27.26 | 50.41 | 67.31 | 91.76 | 60.70 | |
| Deferred Tax Liabilities [Net] | 53.71 | 49.72 | 42.47 | 30.27 | 28.16 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 80.97 | 100.14 | 109.78 | 122.03 | 88.87 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 5.59 | 2.22 | 18.77 | 62.19 | 89.48 | |
| Trade Payables | 149.63 | 146.05 | 130.82 | 87.83 | 83.93 | |
| Other Current Liabilities | 13.61 | 15.55 | 27.01 | 36.11 | 31.23 | |
| Short Term Provisions | 96.42 | 48.91 | 36.47 | 1.94 | 15.76 | |
| Total Current Liabilities | 265.26 | 212.74 | 213.06 | 188.06 | 220.40 | |
| Total Capital And Liabilities | 1,888.30 | 1,574.66 | 1,196.83 | 852.14 | 650.08 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 589.67 | 589.67 | 496.87 | 381.19 | 214.77 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 23.75 | 19.50 | 63.08 | 38.25 | 80.27 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 613.42 | 609.17 | 559.95 | 419.44 | 295.05 | |
| Non-Current Investments | 441.86 | 172.39 | 56.15 | 0.58 | 0.40 | |
| Deferred Tax Assets [Net] | 1.81 | 1.16 | 1.17 | 0.74 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 1,057.09 | 782.72 | 617.27 | 420.76 | 295.44 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 479.57 | 395.91 | 275.66 | 210.05 | 183.86 | |
| Trade Receivables | 234.44 | 283.50 | 214.25 | 164.46 | 107.44 | |
| Cash And Cash Equivalents | 12.87 | 12.87 | 12.61 | 17.22 | 10.15 | |
| Short Term Loans And Advances | 104.33 | 99.67 | 77.05 | 39.65 | 53.19 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 831.21 | 791.95 | 579.55 | 431.38 | 354.64 | |
| Total Assets | 1,888.30 | 1,574.66 | 1,196.83 | 852.14 | 650.08 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 97.21 | 86.94 | 114.67 | 117.62 | 38.32 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 130.13 | 247.79 | 211.01 | 158.03 | 108.23 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.92 | 7.35 | 8.61 | 12.85 | 1.44 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 4.88 | 6.89 | 7.38 | 4.90 | 8.94 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | 0.02 | 0.01 | -- | 0.01 | 0.11 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 835.40 | 1,103.35 | 962.82 | 671.21 | 334.80 | |
| Other Earnings | 7.57 | 3.48 | 4.18 | 3.04 | 3.59 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 13.12 | 0.15 | 0.15 | 0.15 | 0.15 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 441.86 | 172.40 | 56.15 | 0.58 | 0.40 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
20.11.2025
Accumulate Divis Laboratories; target of Rs 6795: Deven Choksey
14.11.2025
Divis Labs Consolidated September 2025 Net Sales at Rs 2,715.00 crore, up 16.12% Y-o-Y
12.11.2025
Neutral Divis Laboratories; target of Rs 6925: Motilal Oswal
12.11.2025
Divis Labs Standalone September 2025 Net Sales at Rs 2,660.00 crore, up 15.55% Y-o-Y
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill